Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting

Clinical Trial ID NCT04370782

Rank	Title	Journal	Year	PubWeight™‹?›
1	Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.	Int J Antimicrob Agents	2020	4.49
2	Zinc for the common cold.	Cochrane Database Syst Rev	2013	2.75
3	Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study.	Antimicrob Agents Chemother	1984	2.40
4	Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides.	J Virol	1976	1.71
5	The mechanism of the antiherpetic activity of zinc sulphate.	J Gen Virol	1990	1.01
6	Inhibition of vaccinia virus maturation by zinc chloride.	Antimicrob Agents Chemother	1981	1.00
7	Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture.	PLoS Pathog	2010	0.99
8	Zinc modulates airway epithelium susceptibility to death receptor-mediated apoptosis.	Am J Physiol Lung Cell Mol Physiol	2005	0.98
9	Effect of zinc salts on respiratory syncytial virus replication.	Antimicrob Agents Chemother	2004	0.94
10	Chloroquine is a zinc ionophore.	PLoS One	2014	0.75